Diridavumab

REQUEST MORE INFO
Catalogue No: abx831308
Price: US$464.00
(Size: 100 µg)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Diridavumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Influenza A Virus Hemagglutinin HA2 Subunit, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Target Influenza A Virus Hemagglutinin HA2 Subunit
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA, WB
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Lambda
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Buffer 0.01 M PBS. pH 7.4.
CAS Number 1393659-46-5
Specificity Binds to Influenza A virus Hemagglutinin HA2 Subunit from various strains.
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 7-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Influenza A Virus Hemagglutinin HA2 Subunit


Write a review